Squarepoint’s iRadimed IRMD Stock Holding History

Squarepoint’s Portfolio IRMD Stock Details IRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$339K	Sell	3,546 -843	-19%	-$76.8K	﹤0.01%	3717
2026 Q1	$422K	Buy	+4,389	New	+$439K	﹤0.01%	3432
2025 Q1	–	Sell	-15,764	Closed	-$867K	–	4996
2024 Q4	$867K	Buy	15,764 +4,591	+41%	+$242K	﹤0.01%	3191
2024 Q3	$562K	Sell	11,173 -10,622	-49%	-$490K	﹤0.01%	3008
2024 Q2	$958K	Buy	21,795 +9,343	+75%	+$397K	﹤0.01%	2582
2024 Q1	$548K	Buy	+12,452	New	+$550K	﹤0.01%	2981
2020 Q2	–	Sell	-13,670	Closed	-$292K	–	2365
2020 Q1	$292K	Sell	13,670 -14,634	-52%	-$348K	0.01%	1313
2019 Q4	$662K	Buy	28,304 +14,672	+108%	+$343K	﹤0.01%	1595
2019 Q3	$287K	Buy	+13,632	New	+$278K	﹤0.01%	1924

Other funds holding IRMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

NTCM

Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Squarepoint's IRMD Position: Q2 2026 in Review

Squarepoint reduced its iRadimed (IRMD) stake by 19% in Q2 2026, selling an estimated $76.8K and leaving 3,546 shares worth $339K. The position accounts for ﹤0.01% of the portfolio, ranked #3717.

Squarepoint first reported a position in IRMD in Q3 2019 and has held it in 9 quarters since. The position peaked at $958K in Q2 2024. 213 funds tracked by Wall St. Rank hold IRMD as of Q2 2026.

Squarepoint held 3,546 shares of iRadimed worth $339K as of Q2 2026.
Squarepoint sold 843 iRadimed shares in Q2 2026, an estimated $76.8K.
iRadimed made up ﹤0.01% of Squarepoint's portfolio in Q2 2026, its #3717 holding.
Squarepoint first reported a position in iRadimed in Q3 2019 and has held it in 9 quarters since.
Squarepoint's iRadimed position peaked at $958K in Q2 2024.
213 funds tracked by Wall St. Rank held iRadimed as of Q2 2026.

Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.